(2R,4R)-Benzyl 4-hydroxy-2-(hydroxymethyl)pyrrolidine-1-carboxylate

Catalog No. :
ACBDHK625
CAS No. :
1009335-39-0
Molecular Formula :
C13H17NO4
Molecular Weight :
251.28

IUPAC Name:benzyl (2R,4R)-4-hydroxy-2-(hydroxymethyl)pyrrolidine-1-carboxylate

(2R,4R)-Benzyl 4-hydroxy-2-(hydroxymethyl)pyrrolidine-1-carboxylate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1g97%$65.00Login to see priceIn stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name(2R,4R)-Benzyl 4-hydroxy-2-(hydroxymethyl)pyrrolidine-1-carboxylate
IUPAC Namebenzyl (2R,4R)-4-hydroxy-2-(hydroxymethyl)pyrrolidine-1-carboxylate
MDL No.MFCD18837818
Molecular FormulaC13H17NO4
Molecular Weight251.28
SMILESO=C(N1[C@@H](CO)C[C@@H](O)C1)OCC2=CC=CC=C2
InChI KeyWDEQGLDWZMIMJM-VXGBXAGGSA-N
Synonym(2R,4R)-benzyl 4-hydroxy-2-(hydroxyMethyl)pyrrolidine-1-carboxylate;N-CBZ-cis-4-Hydroxy-L-prolinol;1-Pyrrolidinecarboxylic acid, 4-hydroxy-2-(hydroxymethyl)-, phenylmethyl ester, (2R,4R)-;N-benzyloxycarbonyl-cis-4-hydroxy-L-prolinol;(2R,4R) -Phenyl-4-hydroxy-2-(hydroxymethyl)pyrrolidine-1-carboxylate;(2R,4R)-N-Cbz-trans-4-hydroxy-D-proline
CAS No.1009335-39-0
PubChem CID59704763

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H315-H319
Precautionary Statement(s)
P264-P280-P302+P352-P305+P351+P338-P332+P313-P337+P313-P362

Synthetic Route by SureRoute

1. ACBDHK625 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACRTCL381 route compound structure diagram
    ACRTCL381155075-23-3 In Stock
  2. Then
  3. ACBDHK625 route product structure diagram
    ACBDHK6251009335-39-0 In Stock
Inquiry

2. ACBDHK625 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACBDHK625 route product structure diagram
    ACBDHK6251009335-39-0 In Stock
Inquiry

Comments (0)